Aug 03, 2016 - Teva Pharmaceutical ([[TEVA]] +1%) CEO Erex Vigodman tells Bloomberg that the completion of its $40.5B purchase of Allergan's ([[AGN]] +1.6%) generics unit
Aug 03, 2016 - How will drug stocks like BMRN, TEVA, REGN and others, scheduled to report on Aug 4, fare this earnings season?
Aug 02, 2016 - Our proven model shows that Teva (TEVA) is likely to beat earnings this quarter because it has the right combination of two key ingredients.
Jul 27, 2016 - The U.S. Federal Trade Commission ((FTC)) accepts the proposed consent order related to Teva Pharmaceutical Industries' ([[TEVA]] +1.4%) acquisition of Act
Jul 27, 2016 - Teva Pharmaceuticals is rapidly expanding on multiple fronts.Huge inroads are in progress to the 115+ billion dollar sales per year Japanese pharmaceutical markets.Latest update on huge 40.5 billion d
Jul 21, 2016 - Teva Pharmaceutical Industries (TEVA) prices a €4B offering of senior notes. The three tranches are: €1.75B of 0.375% fixed rate senior notes due 2020: 99.
Jul 19, 2016 - Teva Pharmaceutical (TEVA) has successfully priced a debt offering for $15M worth of senior notes, maturing between 2018 and 2046, to help fund its acquisi
Jul 14, 2016 - Allergan's sale of its generic business to Teva is proceeding.Closing the Teva transaction should be a major catalyst for Allergan shares.Capital allocation plan balances M&A flexibility, debt pay dow
Jul 14, 2016 - Companies In The News are:
Jul 14, 2016 - Teva (TEVA) provided its preliminary outlook for 2016-2019 and expects the Actavis Generics acquisition to go through anytime soon.